Sorrento Therapeutics (SRNE)
(Delayed Data from OTC)
$0.01 USD
0.00 (-22.07%)
Updated May 31, 2024 03:53 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Sorrento Therapeutics, Inc. [SRNE]
Reports for Purchase
Showing records 41 - 60 ( 186 total )
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Mexican Regulatory Agency Authorizes COVI-STIX; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Multiple Advances on COVID-19 Front; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: COVID (Abivertinib) Completes P2 Enrollment in U.S. and Brazil
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVI-DROPS Phase 2 Trial Authorization; Second Sofusa Program Advances; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Intriguing HER2-Targeted ADC Phase 1 Data Presented at ASCO; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: COVI-STIX - Approved Point of Care Rapid Test, ASCO & ACEA, too
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Next-Generation Natural Killer Cell Platform Collaboration Inked; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Progress Across Pipeline; COVID-19 Rapid Detection Test Clearance; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Therapeutics Maturing; 1Q21 Financial Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Sti-3031 (Anti-Pd-L1) for Urothelial Carcinoma
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Monoclonal Antibody Portfolio Advances; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Portfolio Advances; ACEA Acquisition; Pipeline Progress; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: Acquires Oncology Company ACEA Therapeutics
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Socazolimab Gets Chinese Breakthrough Therapy Designation; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
New Subsidiary to Develop Next-Generation Antibody Drugs; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
COVID-19 Therapeutics Show Promise; Awaiting Controlled Trials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Portfolio Diversity Underrated; COVID-19 Pipeline Catalysts; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: EUA Submitted to the FDA for COVI-STIX
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Sorrento Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
BUY: IND Filing at FDA for COVI-AMG - Accepted
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J